Discontinuation of development of RTA402 (bardoxolone methyl)
A program for RTA402 (bardoxolone methyl) that, following development progress including the initiation of a Phase III trial in Japan, was discontinued in 2023.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.